Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients
- PMID: 20582173
- PMCID: PMC2883203
- DOI: 10.4103/1817-1737.62471
Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients
Abstract
Background: Pulmonary hypertension (PH) occurs in many patients with interstitial lung disease, including sarcoidosis. We explored the frequency, clinical characteristics and outcomes of PH in Arab patients diagnosed with pulmonary sarcoidosis.
Methods: A retrospective study in three tertiary hospitals was performed on 96 patients who underwent Doppler echocardiography. Demographic and clinical characteristics, physiological studies and computed tomography (CT) results were collected, and compared between patients with and without PH.
Results: Twenty (20.8%) patients were found to have PH. Patients with PH were more likely to be symptomatic (cough, P = 0.008; dyspnea, P = 0.04), to have an advanced radiographic stage (P = 0.001), and to be receiving systemic therapy (P = 0.001), compared to those without PH. Physiological data including pulmonary function test parameters, arterial blood gas levels and oxygen saturation at rest and after exercise were all significantly lower in patients with PH compared to those without PH. Comparison of CT patterns between patients with and without PH showed significant differences in the frequencies of ground-glass opacity (61.5 vs. 28.8%, P = 0.032) and fibrosis (76.9 vs. 44.2%, P = 0.035). In total, four patients died during the study period, including three with evidence of PH.
Conclusions: The frequency of PH in the present study was 20.8%. Clinical, physiologic and radiographic characteristics appeared to differentiate patients with PH from those without PH. The presence of PH contributed to poor outcomes in patients with pulmonary sarcoidosis.
Keywords: Computed tomography; echocardiography; pulmonary function test; pulmonary hypertension; sarcoidosis.
Conflict of interest statement
Figures




Similar articles
-
Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.Int J Tuberc Lung Dis. 2013 Mar;17(3):406-11. doi: 10.5588/ijtld.12.0428. Int J Tuberc Lung Dis. 2013. PMID: 23407231
-
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.Chest. 2006 May;129(5):1246-52. doi: 10.1378/chest.129.5.1246. Chest. 2006. PMID: 16685015
-
Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.Chest. 2005 Sep;128(3):1483-9. doi: 10.1378/chest.128.3.1483. Chest. 2005. PMID: 16162747
-
Pulmonary hypertension in chronic lung diseases.J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
-
Sarcoidosis-Associated Pulmonary Hypertension.Semin Respir Crit Care Med. 2020 Oct;41(5):659-672. doi: 10.1055/s-0040-1713615. Epub 2020 Aug 10. Semin Respir Crit Care Med. 2020. PMID: 32777851 Review.
Cited by
-
Patient reported outcome measures (PROMs) in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):2-17. doi: 10.36141/svdld.v34i1.5760. Epub 2017 Apr 28. Sarcoidosis Vasc Diffuse Lung Dis. 2017. PMID: 32476819 Free PMC article. Review.
-
Pulmonary hypertension in patients with sarcoidosis: A single-center experience.Anatol J Cardiol. 2021 Jan;25(1):36-41. doi: 10.14744/AnatolJCardiol.2020.88054. Anatol J Cardiol. 2021. PMID: 33382054 Free PMC article.
-
Sarcoidosis in the eastern region of Saudi Arabia.Ann Thorac Med. 2011 Jan;6(1):22-4. doi: 10.4103/1817-1737.74272. Ann Thorac Med. 2011. PMID: 21264167 Free PMC article.
-
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.Am J Respir Crit Care Med. 2020 Apr 15;201(8):e26-e51. doi: 10.1164/rccm.202002-0251ST. Am J Respir Crit Care Med. 2020. PMID: 32293205 Free PMC article.
-
Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):234-238. doi: 10.36141/svdld.v37i2.9343. Epub 2020 Jun 30. Sarcoidosis Vasc Diffuse Lung Dis. 2020. PMID: 33093789 Free PMC article.
References
-
- Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl. 2001;32:56s–68. - PubMed
-
- Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducoloné A, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:189–94. - PubMed
-
- Chang B, Wigley FM, White B, Wise RA. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol. 2003;30:2398–405. - PubMed
-
- Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746–52. - PubMed
-
- Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest. 2003;124:922–8. - PubMed